Background: In the United States alone, Type 2 Diabetes is the 7th leading cause of death, with Alzheimer’s Disease ahead as the 6th leading cause of mortality. While specific mechanisms have yet to be recognized by mainstream medicine, the term Type 3 Diabetes has been adopted to describe diabetes of the brain. Overarching commonalities amongst each disease include (a) oxidative stress, (b) inflammation, (c) mitochondrial dysfunction, and (d) neuroendocrine abnormalities. Collectively, these factors have been found to directly contribute to pro-death genes, impaired energy metabolism, and cerebral hypoperfusion. Yet, Type 2 Diabetes remains one of the most adjustable risk factors for the development of Alzheimer’s Disease. This dissertation explores the available literature on increasing the awareness of Type 3 Diabetes in terms of present and future implications.
Methods: The review highlighted the following topics: (a) Alzheimer’s disease, (b) Types 1 and 2 diabetes, (c) insulin resistance and cognitive decline, (d) Type 3 diabetes (e) ApoE(4) genetic perturbations, (f) prevention and lifestyle support for Alzheimer’s disease, (g) prevention and lifestyle support for diabetes, (h) social and economic consequences of Alzheimer’s disease, (I) social and economic consequences of diabetes.
Results: While AD is a complex disorder, there is a plethora of irrefutable research that supports viewing it as Type 3 Diabetes. Increasing patient education of Type 3 Diabetes and focusing on prevention strategies would decrease disease burden, increase quality of life and at the same time, save trillions of dollars in healthcare spending.
Conclusions: Since there is no pharmaceutical cure for AD, increasing awareness of Type 3 Diabetes has the potential to provide patients with sustainable, integrative therapies, allowing them to become invested in their health choices. This will also promote individual accountability and a sense of conscientiousness in taking back one’s own health through lifestyle choices while reducing unnecessary suffering for patients, family members and society.
|Advisor:||Grazia, Albert, Coetzee, Oscar|
|School:||University of Bridgeport|
|School Location:||United States -- Connecticut|
|Source:||DAI-B 81/3(E), Dissertation Abstracts International|
|Subjects:||Health sciences, Aging, Medicine|
|Keywords:||Alzheimer's Disease, Cognitive decline, Inflammation, Prediabetes, Type 2 diabetes, Type 3 diabetes|
Copyright in each Dissertation and Thesis is retained by the author. All Rights Reserved
The supplemental file or files you are about to download were provided to ProQuest by the author as part of a
dissertation or thesis. The supplemental files are provided "AS IS" without warranty. ProQuest is not responsible for the
content, format or impact on the supplemental file(s) on our system. in some cases, the file type may be unknown or
may be a .exe file. We recommend caution as you open such files.
Copyright of the original materials contained in the supplemental file is retained by the author and your access to the
supplemental files is subject to the ProQuest Terms and Conditions of use.
Depending on the size of the file(s) you are downloading, the system may take some time to download them. Please be